The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2009

Míreanna comhchosúla

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma
de réir: Marta Cesca, et al.
Foilsithe / Cruthaithe: (2009-11-01)

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
de réir: Edmond Auzenne, et al.
Foilsithe / Cruthaithe: (2007-06-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
de réir: Wachsberger, P, et al.
Foilsithe / Cruthaithe: (2009)

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
de réir: Lavinia Morosi, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
de réir: Choi, S, et al.
Foilsithe / Cruthaithe: (2008)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
de réir: Demuytere J, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
de réir: Martina Vescio, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
de réir: Hideki Iwamoto, et al.
Foilsithe / Cruthaithe: (2011-03-01)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
de réir: Cervellini, I, et al.
Foilsithe / Cruthaithe: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
de réir: Tai, J, et al.
Foilsithe / Cruthaithe: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
de réir: Tai, J, et al.
Foilsithe / Cruthaithe: (2010)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
de réir: Nils Degrauwe, et al.
Foilsithe / Cruthaithe: (2012-06-01)

Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer
de réir: Xiao W, et al.
Foilsithe / Cruthaithe: (2012-03-01)

Selective use of vandetanib in the treatment of thyroid cancer
de réir: Fallahi P, et al.
Foilsithe / Cruthaithe: (2015-07-01)

PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models
de réir: Lavinia Morosi, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Assessment of Acute Antivascular Effects of Vandetanib with High-Resolution Dynamic Contrast-Enhanced Computed Tomographic Imaging in a Human Colon Tumor Xenograft Model in the Nude Rat
de réir: Joo Ho Tai, et al.
Foilsithe / Cruthaithe: (2010-09-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
de réir: Kabir, Md Zahirul, et al.
Foilsithe / Cruthaithe: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
de réir: Abdul Qadir, MPhil, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
de réir: Jade Cury-Martins, et al.
Foilsithe / Cruthaithe: (2018-10-01)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
de réir: Roberta Affatato, et al.
Foilsithe / Cruthaithe: (2022-05-01)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
de réir: Zhou, J, et al.
Foilsithe / Cruthaithe: (2016)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
de réir: Alferez, D, et al.
Foilsithe / Cruthaithe: (2010)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
de réir: Francesca Ricci, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
de réir: Heymach, J, et al.
Foilsithe / Cruthaithe: (2008)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
de réir: Siemann, D, et al.
Foilsithe / Cruthaithe: (2009)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
de réir: Yuxin Shen, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
de réir: Hari Deshpande, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer
de réir: Dong Choon Park, et al.
Foilsithe / Cruthaithe: (2008-09-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
de réir: Ai Matsui, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
de réir: Joseph J. Caumanns, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
de réir: Paola De Feudis, et al.
Foilsithe / Cruthaithe: (2000-05-01)

Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
de réir: Robert J G Cardnell, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
de réir: Fallahi P, et al.
Foilsithe / Cruthaithe: (2019-08-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
de réir: T. Laragione, et al.
Foilsithe / Cruthaithe: (2005-01-01)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
de réir: Busra Demirbag Gul, et al.
Foilsithe / Cruthaithe: (2022-02-01)

LAMININ-5. A POTENTIAL TOOL IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
de réir: Hartwig Kosmehl, et al.
Foilsithe / Cruthaithe: (2002-12-01)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
de réir: E. A. Samishina, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel
de réir: Pepe D, et al.
Foilsithe / Cruthaithe: (2016-05-01)

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
de réir: Jr, W, et al.
Foilsithe / Cruthaithe: (2012)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
de réir: Carlos M. Galmarini, et al.
Foilsithe / Cruthaithe: (2014-01-01)